Hair loss can be frustrating for most because it’s often hard to manage. It’s no surprise that more people are turning to ...

Navigating male hair loss can be tricky, especially given the sea of over-the-counter and prescription treatments flooding ...

Hair loss is a widespread problem in the US, with roughly 50 million men and 30 million women experiencing pattern baldness.

More than 20,000 people are taking Eli Lilly's new GLP-1 weight loss pill approved earlier this month, and company executives expect that number to keep growing as Lilly continues its hold on the ...

This treatment is now in late-stage testing ahead of potential FDA review. New oral hair loss pill in phase 3 trials shows promising regrowth results. VDPHL01 pill is an extended-release version of ...

On April 27, 2026, Veradermics, Inc. disclosed that its experimental oral hair-loss drug VDPHL01 hit the primary efficacy endpoint in Study 302, a late-stage, placebo-controlled trial enrolling men ...

Once- and twice-daily VDPHL01 significantly increased nonvellus hair counts and improved coverage in men with androgenetic alopecia. Topline data were announced from a phase 2/3 trial evaluating ...

Hair loss has long confounded the pharmaceutical industry, but there’s hope on the horizon. Veradermics has announced success in its late-stage clinical trial with a drug to reverse hair loss. The ...

Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss VDPHL01, a novel orally-administered extended-release ...